(PDF) Budget Impact Analysis of Vildagliptin Treating T2dm

Budget Impact Analysis of Vildagliptin Treating T2dm in China

Value in Health - United Kingdom

doi 10.1016/j.jval.2016.03.1284

Full Text

Abstract

Available in full text

Categories

Occupational Health

Date

May 1, 2016

Authors

Publisher

Elsevier BV

Related search

Pcv46 - Pharmacoeconomic Evaluation and Budget Impact Analysis of Ivabradine in China

Value in Health

Occupational Health

English

Saxagliptin/Metformin Extended-Release (XR) for the Type 2 Diabetes (T2DM) Treatment in Venezuela: A Budget Impact Analysis

Value in Health

Occupational Health

English

Budget Impact Analysis of Utilizing Canagliflozin (CANA) for the Treatment of Type 2 Diabetes Mellitus (T2DM) in an United States Health Plan

Value in Health

Occupational Health

English

Pdb38 - Budget Impact Analysis of Benaglutide Injection in the Treatment of Type 2 Diabetes in China

Value in Health

Occupational Health

English

Pmd40 - The Budget Impact and Cost-Consequence of Treating Leg Ulcers With Urgostart

Value in Health

Occupational Health

English

Budget Impact Analysis of Liposomal Amphotericin B and Amphotericin B Lipid Complex for Treating Invasive Fungal Infections in Hospitalized Patients

Value in Health

Occupational Health

English

Perioperative Antibiotic Prophylaxis: Budget Impact Analysis

Vestnik of Saint Petersburg University. Medicine

English

Pss14 - Budget Impact Analysis of Conbercept and Ranibizumab in Patients With Wet Age-Related Macular Degeneration in China

Value in Health

Occupational Health

English

Pmd41 - The Budget Impact and Cost-Consequence of Treating Diabetic Foot Ulcers With Urgostart

Value in Health

Occupational Health

English